Hae
Aineistot 1-6 / 6
Ultrasensitive heterogeneous bioaffinity assays by eliminating nonspecific binding of upconverting nanoparticles
(Turun yliopisto, 2025-05-16)
Bioaffinity assays are commonly used for specific detection of biomarkers in biological samples. Reducing the lowest detectable concentration, i.e. the analytical sensitivity of such assays, is beneficial for several ...
Advancing antibody engineering: Development of a novel Bxb1 landing pad-based mammalian display platform for the selection of biophysically favorable antibodies
(Turun yliopisto, 2024-12-13)
Owing to their high clinical success rate, advancements in biotechnology, and increased understanding of disease mechanisms, therapeutic antibodies have become an important modality for the treatment of many diseases. ...
Novel circulatory biomarkers for ovarian cancer diagnosis: Nanoparticle based glycovariant assays
(Turun yliopisto, 2024-12-05)
Ovarian cancer is the most lethal gynecological malignancy and the seventh most common cancer worldwide. Current diagnosis options for ovarian cancer suffer from a lack of sensitivity and specificity that lead to either ...
Additive manufacturing of polymer-based drug delivery systems: Effects of semi-solid ink composition and manufacturing process parameters on structural and drug release properties
(Turun yliopisto, 2025-11-28)
Controlled release drug delivery systems enable the maintenance of drug levels within the therapeutic window for extended periods, thereby enhancing the treatment efficacy and patient compliance. However, there is a growing ...
Phage display based approach for identifying novel HDL particle binders: Recombinant HDL antibodies as novel diagnostic tool for risk assessment and monitoring of coronary artery disease
(Turun yliopisto, 2022-11-11)
Cholesterol content of high density lipoprotein (HDL-C) has been a well established cardiac risk marker for coronary artery disease (CAD), a major cause of mortality worldwide. Various epidemiological and experimental ...
Diagnostic and prognostic value of free PAPP-A in coronary artery disease – clinical studies with novel immunoassay
(Turun yliopisto, 2022-12-09)
Complications of coronary artery disease are the number one cause of death worldwide, so identification of high-risk individuals is crucial. Pregnancy-associated plasma protein A (PAPP-A) is a candidate cardiac-risk related ...





